Evidence map›Paper›PMID 39768361›Full record

ArticleLife (Basel, Switzerland)2024

Quaternary Ammonium Silica Nanoparticles for Antimicrobial Implantable Medical Devices: An In Vitro Study.

Eitam Weiss, Ariel Berl, Ofir Shir-Az, Biader Samih Bilal, Ervin I Weiss, Yossi Paitan, Natan Zaltsman, Alexander Golberg, Avshalom Shalom

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eitam WeissDepartment of Plastic Surgery, Meir Medical Center, Kfar Saba 4428164, Israel.
Ariel BerlDepartment of Plastic Surgery, Meir Medical Center, Kfar Saba 4428164, Israel.ORCID 0000-0003-3705-5454
Ofir Shir-AzDepartment of Plastic Surgery, Meir Medical Center, Kfar Saba 4428164, Israel.
Biader Samih BilalDepartment of Plastic Surgery, Meir Medical Center, Kfar Saba 4428164, Israel.ORCID 0000-0003-3627-2959
Ervin I WeissSchool of Dental Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0001-8639-9507
Yossi PaitanClinical Microbiology Laboratory, Meir Medical Center, Kfar Saba 4428164, Israel.
Natan ZaltsmanDepartment of Research and Development, Nobio, Ltd., Kadima 6092000, Israel.
Alexander GolbergSchool of Mechanical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv 6997801, Israel.
Avshalom ShalomDepartment of Plastic Surgery, Meir Medical Center, Kfar Saba 4428164, Israel.ORCID 0000-0003-2074-1650

Funding

Nobio, LTD, Kadima, Israel, supplied materials for the study. There were no other sources of funding.
6 · The paper itself

Abstract

Biofilm formation on prostheses and implanted devices can lead to serious complications and increased healthcare expenditures. Once formed, biofilm management is difficult and may involve a long course of antibiotics, additional surgery, and, occasionally, implant removal. This study evaluated the antibacterial properties of medical-grade silicone samples integrated with novel, non-leaching, antibacterial, quaternary ammonium silica (QASi) particles. Our collaborators (Nobio, Israel) prepared silicone sheets integrated with antibacterial QASi nanoparticles. Samples containing 0.5%, 0.75%, and 1%, QASi particles were evaluated for antibacterial properties against

Indexed as

antibacterial technologyantimicrobial QASi particlesbiofilmnanoparticlessilicone

Identifiers

PMID39768361
PMCPMC11678768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.